Amgen (AMGN) Misses Q2 EPS by 1c; updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $401.99 -0.26%
EPS Growth %: +2.7%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
EPS Growth %: +2.7%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $4.97, $0.01 worse than the analyst estimate of $4.98. Revenue for the quarter came in at $8.39 billion versus the consensus estimate of $8.35 billion.
GUIDANCE:
Amgen sees FY2024 EPS of $19.10-$20.10, versus the consensus of $17.87. Amgen sees FY2024 revenue of $32.8-33.8 billion, versus the consensus of $30.3 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs sees AI investment adding to European growth in 2026
- Five9 (FIVN) call put ratio 1 call 6.8 puts with a focus on 3500 contracts of January 32.50 puts
- Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
